[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Anticancer Drugs Market Report 2018

January 2018 | 100 pages | ID: UE29FF47369EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Anticancer Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Anticancer Drugs in these regions, from 2013 to 2025 (forecast).
United States Anticancer Drugs market competition by top manufacturers/players, with Anticancer Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • Bayer AG
  • Eli Lilly and Company
  • Amgen Inc
  • AstraZeneca
  • Pfizer Inc
  • Merck & Co., Inc.
  • Takeda Pharmaceutical Company Limited
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Hormonal Drugs
  • Targeted Drugs
  • Cytotoxic Drugs
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Anticancer Drugs Market Report 2018

1 ANTICANCER DRUGS OVERVIEW

1.1 Product Overview and Scope of Anticancer Drugs
1.2 Classification of Anticancer Drugs by Product Category
  1.2.1 United States Anticancer Drugs Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Anticancer Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Hormonal Drugs
  1.2.4 Targeted Drugs
  1.2.5 Cytotoxic Drugs
1.3 United States Anticancer Drugs Market by Application/End Users
  1.3.1 United States Anticancer Drugs Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Chemotherapy
  1.3.3 Immunotherapy
  1.3.4 Targeted Therapy
1.4 United States Anticancer Drugs Market by Region
  1.4.1 United States Anticancer Drugs Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Anticancer Drugs Status and Prospect (2013-2025)
  1.4.3 Southwest Anticancer Drugs Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Anticancer Drugs Status and Prospect (2013-2025)
  1.4.5 New England Anticancer Drugs Status and Prospect (2013-2025)
  1.4.6 The South Anticancer Drugs Status and Prospect (2013-2025)
  1.4.7 The Midwest Anticancer Drugs Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Anticancer Drugs (2013-2025)
  1.5.1 United States Anticancer Drugs Sales and Growth Rate (2013-2025)
  1.5.2 United States Anticancer Drugs Revenue and Growth Rate (2013-2025)

2 UNITED STATES ANTICANCER DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Anticancer Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Anticancer Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Anticancer Drugs Average Price by Players/Suppliers (2013-2018)
2.4 United States Anticancer Drugs Market Competitive Situation and Trends
  2.4.1 United States Anticancer Drugs Market Concentration Rate
  2.4.2 United States Anticancer Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Anticancer Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ANTICANCER DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Anticancer Drugs Sales and Market Share by Region (2013-2018)
3.2 United States Anticancer Drugs Revenue and Market Share by Region (2013-2018)
3.3 United States Anticancer Drugs Price by Region (2013-2018)

4 UNITED STATES ANTICANCER DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Anticancer Drugs Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Anticancer Drugs Revenue and Market Share by Type (2013-2018)
4.3 United States Anticancer Drugs Price by Type (2013-2018)
4.4 United States Anticancer Drugs Sales Growth Rate by Type (2013-2018)

5 UNITED STATES ANTICANCER DRUGS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Anticancer Drugs Sales and Market Share by Application (2013-2018)
5.2 United States Anticancer Drugs Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANTICANCER DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 F. Hoffmann-La Roche Ltd
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Anticancer Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 F. Hoffmann-La Roche Ltd Anticancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Novartis AG
  6.2.2 Anticancer Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Novartis AG Anticancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Bayer AG
  6.3.2 Anticancer Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bayer AG Anticancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Eli Lilly and Company
  6.4.2 Anticancer Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Eli Lilly and Company Anticancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Amgen Inc
  6.5.2 Anticancer Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Amgen Inc Anticancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 AstraZeneca
  6.6.2 Anticancer Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 AstraZeneca Anticancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Pfizer Inc
  6.7.2 Anticancer Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Pfizer Inc Anticancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Merck & Co., Inc.
  6.8.2 Anticancer Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Merck & Co., Inc. Anticancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Takeda Pharmaceutical Company Limited
  6.9.2 Anticancer Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Takeda Pharmaceutical Company Limited Anticancer Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview

7 ANTICANCER DRUGS MANUFACTURING COST ANALYSIS

7.1 Anticancer Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anticancer Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Anticancer Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anticancer Drugs Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANTICANCER DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Anticancer Drugs Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Anticancer Drugs Sales Volume Forecast by Type (2018-2025)
11.3 United States Anticancer Drugs Sales Volume Forecast by Application (2018-2025)
11.4 United States Anticancer Drugs Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Anticancer Drugs
Figure United States Anticancer Drugs Market Size (MT) by Type (2013-2025)
Figure United States Anticancer Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Hormonal Drugs Product Picture
Figure Targeted Drugs Product Picture
Figure Cytotoxic Drugs Product Picture
Figure United States Anticancer Drugs Market Size (MT) by Application (2013-2025)
Figure United States Sales Market Share of Anticancer Drugs by Application in 2017
Figure Chemotherapy Examples
Table Key Downstream Customer in Chemotherapy
Figure Immunotherapy Examples
Table Key Downstream Customer in Immunotherapy
Figure Targeted Therapy Examples
Table Key Downstream Customer in Targeted Therapy
Figure United States Anticancer Drugs Market Size (Million USD) by Region (2013-2025)
Figure The West Anticancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Anticancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Anticancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Anticancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Anticancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Anticancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Anticancer Drugs Sales (MT) and Growth Rate (2013-2025)
Figure United States Anticancer Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Anticancer Drugs Market Major Players Product Sales Volume (MT) (2013-2018)
Table United States Anticancer Drugs Sales (MT) of Key Players/Suppliers (2013-2018)
Table United States Anticancer Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Anticancer Drugs Sales Share by Players/Suppliers
Figure 2017 United States Anticancer Drugs Sales Share by Players/Suppliers
Figure United States Anticancer Drugs Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Anticancer Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Anticancer Drugs Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Anticancer Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Anticancer Drugs Revenue Share by Players/Suppliers
Table United States Market Anticancer Drugs Average Price (USD/Kg) of Key Players/Suppliers (2013-2018)
Figure United States Market Anticancer Drugs Average Price (USD/Kg) of Key Players/Suppliers in 2017
Figure United States Anticancer Drugs Market Share of Top 3 Players/Suppliers
Figure United States Anticancer Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Anticancer Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Anticancer Drugs Product Category
Table United States Anticancer Drugs Sales (MT) by Region (2013-2018)
Table United States Anticancer Drugs Sales Share by Region (2013-2018)
Figure United States Anticancer Drugs Sales Share by Region (2013-2018)
Figure United States Anticancer Drugs Sales Market Share by Region in 2017
Table United States Anticancer Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Anticancer Drugs Revenue Share by Region (2013-2018)
Figure United States Anticancer Drugs Revenue Market Share by Region (2013-2018)
Figure United States Anticancer Drugs Revenue Market Share by Region in 2017
Table United States Anticancer Drugs Price (USD/Kg) by Region (2013-2018)
Table United States Anticancer Drugs Sales (MT) by Type (2013-2018)
Table United States Anticancer Drugs Sales Share by Type (2013-2018)
Figure United States Anticancer Drugs Sales Share by Type (2013-2018)
Figure United States Anticancer Drugs Sales Market Share by Type in 2017
Table United States Anticancer Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Anticancer Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Anticancer Drugs by Type (2013-2018)
Figure Revenue Market Share of Anticancer Drugs by Type in 2017
Table United States Anticancer Drugs Price (USD/Kg) by Types (2013-2018)
Figure United States Anticancer Drugs Sales Growth Rate by Type (2013-2018)
Table United States Anticancer Drugs Sales (MT) by Application (2013-2018)
Table United States Anticancer Drugs Sales Market Share by Application (2013-2018)
Figure United States Anticancer Drugs Sales Market Share by Application (2013-2018)
Figure United States Anticancer Drugs Sales Market Share by Application in 2017
Table United States Anticancer Drugs Sales Growth Rate by Application (2013-2018)
Figure United States Anticancer Drugs Sales Growth Rate by Application (2013-2018)
Table F. Hoffmann-La Roche Ltd Basic Information List
Table F. Hoffmann-La Roche Ltd Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure F. Hoffmann-La Roche Ltd Anticancer Drugs Sales Growth Rate (2013-2018)
Figure F. Hoffmann-La Roche Ltd Anticancer Drugs Sales Market Share in United States (2013-2018)
Figure F. Hoffmann-La Roche Ltd Anticancer Drugs Revenue Market Share in United States (2013-2018)
Table Novartis AG Basic Information List
Table Novartis AG Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Novartis AG Anticancer Drugs Sales Growth Rate (2013-2018)
Figure Novartis AG Anticancer Drugs Sales Market Share in United States (2013-2018)
Figure Novartis AG Anticancer Drugs Revenue Market Share in United States (2013-2018)
Table Bayer AG Basic Information List
Table Bayer AG Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Bayer AG Anticancer Drugs Sales Growth Rate (2013-2018)
Figure Bayer AG Anticancer Drugs Sales Market Share in United States (2013-2018)
Figure Bayer AG Anticancer Drugs Revenue Market Share in United States (2013-2018)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Eli Lilly and Company Anticancer Drugs Sales Growth Rate (2013-2018)
Figure Eli Lilly and Company Anticancer Drugs Sales Market Share in United States (2013-2018)
Figure Eli Lilly and Company Anticancer Drugs Revenue Market Share in United States (2013-2018)
Table Amgen Inc Basic Information List
Table Amgen Inc Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Amgen Inc Anticancer Drugs Sales Growth Rate (2013-2018)
Figure Amgen Inc Anticancer Drugs Sales Market Share in United States (2013-2018)
Figure Amgen Inc Anticancer Drugs Revenue Market Share in United States (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure AstraZeneca Anticancer Drugs Sales Growth Rate (2013-2018)
Figure AstraZeneca Anticancer Drugs Sales Market Share in United States (2013-2018)
Figure AstraZeneca Anticancer Drugs Revenue Market Share in United States (2013-2018)
Table Pfizer Inc Basic Information List
Table Pfizer Inc Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Pfizer Inc Anticancer Drugs Sales Growth Rate (2013-2018)
Figure Pfizer Inc Anticancer Drugs Sales Market Share in United States (2013-2018)
Figure Pfizer Inc Anticancer Drugs Revenue Market Share in United States (2013-2018)
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Merck & Co., Inc. Anticancer Drugs Sales Growth Rate (2013-2018)
Figure Merck & Co., Inc. Anticancer Drugs Sales Market Share in United States (2013-2018)
Figure Merck & Co., Inc. Anticancer Drugs Revenue Market Share in United States (2013-2018)
Table Takeda Pharmaceutical Company Limited Basic Information List
Table Takeda Pharmaceutical Company Limited Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Takeda Pharmaceutical Company Limited Anticancer Drugs Sales Growth Rate (2013-2018)
Figure Takeda Pharmaceutical Company Limited Anticancer Drugs Sales Market Share in United States (2013-2018)
Figure Takeda Pharmaceutical Company Limited Anticancer Drugs Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anticancer Drugs
Figure Manufacturing Process Analysis of Anticancer Drugs
Figure Anticancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anticancer Drugs Major Players/Suppliers in 2017
Table Major Buyers of Anticancer Drugs
Table Distributors/Traders List
Figure United States Anticancer Drugs Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure United States Anticancer Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Anticancer Drugs Price (USD/Kg) Trend Forecast (2018-2025)
Table United States Anticancer Drugs Sales Volume (MT) Forecast by Type (2018-2025)
Figure United States Anticancer Drugs Sales Volume (MT) Forecast by Type (2018-2025)
Figure United States Anticancer Drugs Sales Volume (MT) Forecast by Type in 2025
Table United States Anticancer Drugs Sales Volume (MT) Forecast by Application (2018-2025)
Figure United States Anticancer Drugs Sales Volume (MT) Forecast by Application (2018-2025)
Figure United States Anticancer Drugs Sales Volume (MT) Forecast by Application in 2025
Table United States Anticancer Drugs Sales Volume (MT) Forecast by Region (2018-2025)
Table United States Anticancer Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Anticancer Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Anticancer Drugs Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories